{
    "clinical_study": {
        "@rank": "85861", 
        "brief_summary": {
            "textblock": "Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine)\n      during recovery by assessing their cognitive function at monthly intervals."
        }, 
        "brief_title": "Cognitive Correlates of Substance Abuse, Part 2 - 16", 
        "condition": "Amphetamine-Related Disorders", 
        "condition_browse": {
            "mesh_term": [
                "Amphetamine-Related Disorders", 
                "Substance-Related Disorders"
            ]
        }, 
        "detailed_description": {
            "textblock": "Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine)\n      during recovery by assessing their cognitive function at monthly intervals."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Please contact site for information\n\n        Inclusion Criteria:\n\n        M/F. Meet DSM-IV criteria for stimulant dependence. Agree to conditions of the study and\n        sign informed consent."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "43", 
        "firstreceived_date": "September 20, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00000351", 
            "org_study_id": "NIDA-3-0010-16"
        }, 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Los Angeles", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "90025"
                }, 
                "name": "Friends Research Institute"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Cognitive Correlates of Substance Abuse, Part 2", 
        "overall_official": {
            "affiliation": "Friends Research Institute, Inc.", 
            "last_name": "Walter Ling, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 4", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000351"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "December 2002"
    }, 
    "geocoordinates": {
        "Friends Research Institute": "34.052 -118.244"
    }
}